Open Payments

JOSHUA W KIM

Type
Physician · Allopathic & Osteopathic Physicians / Ophthalmology
Where
VENICE, FL
NPI
1740391952
Received
$210,490 in 433 records, 2019 to 2025 ($199,923 general, $10,566 research)
As principal investigator
$477,317 of research payments to others in 254 records
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment40$6,947
2024General payment46$27,360
2023General payment61$23,769
2022General payment44$29,456
2021General payment66$32,333
2020General payment38$16,994
2019General payment134$63,061
2019Research payment4$10,566

By company

CompanyRecordsAmountYears
ABBVIE INC.62$51,4372022–2025
Aerie Pharmaceuticals, Inc.71$50,9012019–2021
Allergan, Inc.95$30,2182019–2022
Glaukos Corporation83$25,7272019–2025
Bausch & Lomb, a division of Bausch Health US, LLC25$19,9482019–2021
Alcon Vision LLC28$16,0472022–2025
Bausch Health US, LLC2$10,2502019
Bausch & Lomb Americas Inc.12$3,2482022–2025
Johnson & Johnson Surgical Vision, Inc.15$7082019–2025
Ivantis, Inc6$4662019–2021
Sight Sciences, Inc.14$3372023–2025
RxSight Inc3$2692022–2025
Tarsus Pharmaceuticals, Inc.2$2432025
NEW WORLD MEDICAL,INC.4$2162023–2025
Nova Eye, Inc.1$1272024
SUN PHARMACEUTICAL INDUSTRIES INC.2$1142021–2022
Apellis Pharmaceuticals, Inc.1$1062023
Rayner Intraocular Lenses Limited3$492022–2024
Omeros Corporation2$382021
Halozyme Inc1$162019
LENSAR, Inc.1$162023

By nature of payment

NatureRecordsAmount
Compensation for services other than consulting, including serving as faculty or as a speaker at a v43$115,833
Consulting Fee14$23,527
Travel and Lodging64$15,903
Acquisitions1$13,903
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing6$13,025
Food and Beverage295$12,756
Research payment4$10,566
Honoraria4$4,500
Compensation for serving as faculty or as a speaker for a medical education program1$375
Gift1$99

Records

DateCompanyAmountNatureFormProductStudyYear
2025-12-16NEW WORLD MEDICAL,INC.$155Food and BeverageIn-kind items and servicesKahook Dual Blade Device, Ophthalmology2025
2025-12-13Johnson & Johnson Surgical Vision, Inc.$48Food and BeverageIn-kind items and services2025
2025-12-04Glaukos Corporation$38Food and BeverageCash or cash equivalentiDoseTR Drug, Ophthalmology2025
2025-12-03ABBVIE INC.$2,175Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2025
2025-11-19Bausch & Lomb Americas Inc.$19Food and BeverageIn-kind items and servicesVYZULTA Drug, Ophthalmology2025
2025-11-19Bausch & Lomb Americas Inc.$2Food and BeverageIn-kind items and servicesVYZULTA Drug, Ophthalmology2025
2025-11-06Tarsus Pharmaceuticals, Inc.$121Food and BeverageIn-kind items and servicesXDEMVY Drug, DEMODEX BLEPHARITIS2025
2025-11-05Bausch & Lomb Americas Inc.$2,550Consulting FeeCash or cash equivalentVYZULTA Drug, Ophthalmology2025
2025-10-29Glaukos Corporation$450Consulting FeeCash or cash equivalentTravoprost Intraocular Implant - iDose Drug, Ophthalmology2025
2025-10-27Glaukos Corporation$28Food and BeverageCash or cash equivalentiDoseTR Drug, Ophthalmology2025
2025-10-23Alcon Vision LLC$120Food and BeverageIn-kind items and servicesClareon Device, Ophthalmology2025
2025-10-17Bausch & Lomb Americas Inc.$89Food and BeverageIn-kind items and servicesVYZULTA Drug, Ophthalmology2025
2025-10-16Sight Sciences, Inc.$22Food and BeverageIn-kind items and servicesOMNI SURGICAL SYSTEM Device, Ophthalmology2025
2025-10-16Sight Sciences, Inc.$18Food and BeverageIn-kind items and servicesOMNI SURGICAL SYSTEM Device, Ophthalmology2025
2025-09-23Alcon Vision LLC$19Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2025
2025-09-10ABBVIE INC.$145Food and BeverageIn-kind items and servicesNATRELLE SALINE-FILLED BREAST IMPLANTS Device, PLASTIC SURGERY2025
2025-08-18NEW WORLD MEDICAL,INC.$18Food and BeverageIn-kind items and servicesKahook Dual Blade Device, Ophthalmology2025
2025-06-19RxSight Inc$115Food and BeverageIn-kind items and servicesRXSIGHT CONTACT LENS Device, OPHTHALMOLOGY2025
2025-06-18Bausch & Lomb Americas Inc.$36Food and BeverageIn-kind items and servicesVYZULTA Drug, Ophthalmology2025
2025-06-05ABBVIE INC.$20Food and BeverageIn-kind items and servicesLUMIGAN Drug, EYE CARE2025
2025-06-03Glaukos Corporation$26Food and BeverageCash or cash equivalentiDoseTR Drug, Ophthalmology2025
2025-06-02Alcon Vision LLC$25Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2025
2025-05-23Johnson & Johnson Surgical Vision, Inc.$27Food and BeverageIn-kind items and services2025
2025-05-12Sight Sciences, Inc.$17Food and BeverageIn-kind items and servicesOMNI SURGICAL SYSTEM Device, Ophthalmology2025
2025-05-05Alcon Vision LLC$16Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2025
2025-04-23Glaukos Corporation$24Food and BeverageCash or cash equivalentiDoseTR Drug, Ophthalmology2025
2025-04-14NEW WORLD MEDICAL,INC.$20Food and BeverageIn-kind items and servicesKahook Dual Blade Device, Ophthalmology2025
2025-04-03Bausch & Lomb Americas Inc.$43Food and BeverageIn-kind items and servicesXIPERE Drug, Ophthalmology2025
2025-03-19Glaukos Corporation$135Food and BeverageCash or cash equivalent2025
2025-03-17Sight Sciences, Inc.$23Food and BeverageIn-kind items and servicesOMNI SURGICAL SYSTEM Device, Ophthalmology2025
2025-03-10Sight Sciences, Inc.$19Food and BeverageIn-kind items and servicesOMNI SURGICAL SYSTEM Device, Ophthalmology2025
2025-03-07Glaukos Corporation$22Food and BeverageCash or cash equivalentRadius XR Device, Ophthalmology2025
2025-03-06ABBVIE INC.$99Food and BeverageIn-kind items and servicesXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2025
2025-02-27Glaukos Corporation$31Food and BeverageCash or cash equivalentiDoseTR Drug, Ophthalmology2025
2025-02-25Alcon Vision LLC$17Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2025
2025-02-19Glaukos Corporation$25Food and BeverageCash or cash equivalentiDoseTR Drug, Ophthalmology2025
2025-02-19Glaukos Corporation$6Food and BeverageCash or cash equivalentiDoseTR Drug, Ophthalmology2025
2025-01-23Tarsus Pharmaceuticals, Inc.$121Food and BeverageIn-kind items and servicesXDEMVY Drug, DEMODEX BLEPHARITIS2025
2025-01-17Glaukos Corporation$28Food and BeverageCash or cash equivalent2025
2025-01-13Glaukos Corporation$21Food and BeverageCash or cash equivalentiDoseTR Drug, Ophthalmology2025
2024-12-03ABBVIE INC.$4,725Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2024
2024-12-02Sight Sciences, Inc.$17Food and BeverageIn-kind items and servicesOMNI SURGICAL SYSTEM Device, Ophthalmology2024
2024-11-25ABBVIE INC.$2,025Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2024
2024-11-14ABBVIE INC.$1,151Travel and LodgingIn-kind items and servicesXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2024
2024-11-14ABBVIE INC.$109Food and BeverageIn-kind items and servicesXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2024
2024-10-30Glaukos Corporation$6,400Consulting FeeCash or cash equivalentiDose Device, Glaucoma2024
2024-10-30ABBVIE INC.$34Food and BeverageIn-kind items and servicesBOTOX Biological, FACIAL AESTHETICS2024
2024-10-22Glaukos Corporation$20Food and BeverageCash or cash equivalentiDose Device, Glaucoma2024
2024-10-02Sight Sciences, Inc.$118Food and BeverageIn-kind items and servicesOMNI SURGICAL SYSTEM Device, Ophthalmology2024
2024-09-18Glaukos Corporation$2,058Travel and LodgingCash or cash equivalentiDose Device, Glaucoma2024
2024-09-18Glaukos Corporation$264Food and BeverageCash or cash equivalentiDose Device, Glaucoma2024
2024-09-18Sight Sciences, Inc.$14Food and BeverageIn-kind items and servicesOMNI SURGICAL SYSTEM Device, Ophthalmology2024
2024-09-17Bausch & Lomb Americas Inc.$22Food and BeverageIn-kind items and servicesVYZULTA Drug, Ophthalmology2024
2024-09-09Sight Sciences, Inc.$16Food and BeverageIn-kind items and servicesOMNI SURGICAL SYSTEM Device, Ophthalmology2024
2024-08-29Glaukos Corporation$26Food and BeverageCash or cash equivalentiDose Device, Glaucoma2024
2024-08-19Glaukos Corporation$27Food and BeverageCash or cash equivalentiDose Device, Glaucoma2024
2024-07-12Glaukos Corporation$20Food and BeverageCash or cash equivalentiDose Device, Glaucoma2024
2024-07-09Nova Eye, Inc.$127Food and Beverage (2 payments)In-kind items and services2024
2024-07-08Sight Sciences, Inc.$16Food and BeverageIn-kind items and servicesOMNI SURGICAL SYSTEM Device, Ophthalmology2024
2024-06-17Glaukos Corporation$26Food and BeverageCash or cash equivalentiDose Device, Glaucoma2024
2024-06-14ABBVIE INC.$31Food and BeverageIn-kind items and servicesDURYSTA Drug, EYE CARE2024
2024-06-03ABBVIE INC.$4,725Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2024
2024-05-21ABBVIE INC.$675Consulting FeeCash or cash equivalentXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2024
2024-05-14Bausch & Lomb Americas Inc.$39Food and BeverageIn-kind items and servicesXIIDRA Drug, Ophthalmology2024
2024-05-13Glaukos Corporation$20Food and BeverageCash or cash equivalentiDose Device, Glaucoma2024
2024-05-09ABBVIE INC.$124Food and BeverageIn-kind items and servicesXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2024
2024-05-09ABBVIE INC.$99Travel and LodgingIn-kind items and servicesXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2024
2024-05-09ABBVIE INC.$17Food and BeverageIn-kind items and servicesXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2024
2024-04-17Glaukos Corporation$1,200Consulting FeeCash or cash equivalentiDose Device, Glaucoma2024
2024-04-09Glaukos Corporation$21Food and BeverageCash or cash equivalentiDose Device, Glaucoma2024
2024-04-08Alcon Vision LLC$19Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2024
2024-04-05ABBVIE INC.$121Food and BeverageIn-kind items and servicesXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2024
2024-03-27ABBVIE INC.$20Food and BeverageIn-kind items and servicesLUMIGAN Drug, EYE CARE2024
2024-03-25Alcon Vision LLC$14Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2024
2024-03-06Glaukos Corporation$2,400Consulting FeeCash or cash equivalentiDose Device, Glaucoma2024
2024-03-04Glaukos Corporation$20Food and BeverageCash or cash equivalentiDose Device, Glaucoma2024
2024-03-01ABBVIE INC.$124Food and BeverageIn-kind items and servicesLUMIGAN Drug, EYE CARE2024
2024-03-01Glaukos Corporation$76Food and BeverageCash or cash equivalentRadius Device, Glaucoma2024
2024-02-28Glaukos Corporation$59Food and BeverageCash or cash equivalentiDose Device, Glaucoma2024
2024-02-16Glaukos Corporation$91Food and BeverageCash or cash equivalent2024
2024-02-12Rayner Intraocular Lenses Limited$18Food and BeverageCash or cash equivalentOmidria Drug, Ophthalmology2024
2024-02-08ABBVIE INC.$32Food and BeverageIn-kind items and servicesLUMIGAN Drug, EYE CARE2024
2024-02-02Johnson & Johnson Surgical Vision, Inc.$130Food and BeverageIn-kind items and services2024
2024-01-22Sight Sciences, Inc.$11Food and BeverageIn-kind items and servicesOMNI SURGICAL SYSTEM Device, Ophthalmology2024
2024-01-10Glaukos Corporation$24Food and BeverageCash or cash equivalentiStent Trabecular Micro-Bypass System Model iS3 Device, Glaucoma2024
2024-01-09Alcon Vision LLC$17Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2024
2023-12-15Glaukos Corporation$10Food and BeverageCash or cash equivalentiStent infinite Trabecular Micro-Bypass System Model iS3 Device, Glaucoma2023
2023-12-15Glaukos Corporation$10Food and BeverageCash or cash equivalentiS3-iStent infiniteTrabecular Micro-Bypass System Model iS3 Device, Glaucoma2023
2023-12-07ABBVIE INC.$21Food and BeverageIn-kind items and servicesALPHAGAN P Drug, EYE CARE2023
2023-12-06ABBVIE INC.$2,025Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2023
2023-12-06Glaukos Corporation$23Food and BeverageCash or cash equivalentiS3-iStent infiniteTrabecular Micro-Bypass System Model iS3 Device, Glaucoma2023
2023-12-06Glaukos Corporation$23Food and BeverageCash or cash equivalentiStent infinite Trabecular Micro-Bypass System Model iS3 Device, Glaucoma2023
2023-11-08Glaukos Corporation$800Consulting FeeCash or cash equivalentiStent Trabecular Micro-Bypass Stent System Device, Glaucoma2023
2023-10-19ABBVIE INC.$29Food and BeverageIn-kind items and servicesLUMIGAN Drug, EYE CARE2023
2023-10-12ABBVIE INC.$124Food and BeverageIn-kind items and servicesXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2023
2023-10-05ABBVIE INC.$4,725Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentLUMIGAN Drug, EYE CARE2023
2023-10-05Rayner Intraocular Lenses Limited$19Food and BeverageCash or cash equivalentOmidria Drug, Ophthalmology2023
2023-10-02Alcon Vision LLC$6Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2023
2023-09-28NEW WORLD MEDICAL,INC.$22Food and BeverageIn-kind items and services2023
2023-09-20ABBVIE INC.$124Food and BeverageIn-kind items and servicesLUMIGAN Drug, EYE CARE2023
2023-09-20ABBVIE INC.$117Travel and LodgingIn-kind items and servicesLUMIGAN Drug, EYE CARE2023
2023-09-20ABBVIE INC.$14Food and BeverageIn-kind items and servicesLUMIGAN Drug, EYE CARE2023
2023-09-19Alcon Vision LLC$16Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2023
2023-09-18Glaukos Corporation$15Food and BeverageCash or cash equivalent2023
2023-09-18Alcon Vision LLC$6Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2023
2023-09-07ABBVIE INC.$4,725Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentLUMIGAN Drug, EYE CARE2023
2023-09-05Bausch & Lomb Americas Inc.$19Food and BeverageIn-kind items and servicesVYZULTA Drug, Ophthalmology2023
2023-08-31ABBVIE INC.$866Travel and LodgingIn-kind items and servicesLUMIGAN Drug, EYE CARE2023
2023-08-31ABBVIE INC.$124Food and BeverageIn-kind items and servicesLUMIGAN Drug, EYE CARE2023
2023-08-31ABBVIE INC.$21Food and BeverageIn-kind items and servicesLUMIGAN Drug, EYE CARE2023
2023-08-11ABBVIE INC.$2,025Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2023
2023-08-03Apellis Pharmaceuticals, Inc.$106Food and BeverageCash or cash equivalentSyfovre Drug, Ophthalmology2023
2023-08-02ABBVIE INC.$13Food and BeverageIn-kind items and servicesALPHAGAN P Drug, EYE CARE2023
2023-08-01Glaukos Corporation$13Food and BeverageCash or cash equivalent2023
2023-07-13ABBVIE INC.$2,025Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2023
2023-06-13ABBVIE INC.$8Food and BeverageIn-kind items and servicesALPHAGAN P Drug, EYE CARE2023
2023-06-12Glaukos Corporation$18Food and BeverageCash or cash equivalent2023
2023-06-05Alcon Vision LLC$16Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2023
2023-05-22Alcon Vision LLC$6Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2023
2023-05-09Glaukos Corporation$27Food and BeverageCash or cash equivalent2023
2023-05-09Sight Sciences, Inc.$13Food and BeverageIn-kind items and servicesOMNI SURGICAL SYSTEM Device, Ophthalmology2023
2023-04-28Alcon Vision LLC$20Food and BeverageIn-kind items and servicesRocklatan Drug, Ophthalmology2023
2023-04-27Alcon Vision LLC$115Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2023
2023-04-24ABBVIE INC.$20Food and BeverageIn-kind items and servicesALPHAGAN P Drug, EYE CARE2023
2023-04-20ABBVIE INC.$3,375Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentLUMIGAN Drug, EYE CARE2023
2023-04-11ABBVIE INC.$125Food and BeverageIn-kind items and servicesXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2023
2023-04-11ABBVIE INC.$22Food and BeverageIn-kind items and servicesXEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE2023
2023-04-10Sight Sciences, Inc.$14Food and BeverageIn-kind items and servicesOMNI SURGICAL SYSTEM Device, Ophthalmology2023
2023-04-06Alcon Vision LLC$1,140Consulting FeeCash or cash equivalentSimbrinza Drug, Ophthalmology2023
2023-03-30ABBVIE INC.$124Food and BeverageIn-kind items and servicesLUMIGAN Drug, EYE CARE2023
2023-03-30ABBVIE INC.$26Travel and LodgingIn-kind items and servicesLUMIGAN Drug, EYE CARE2023
2023-03-30ABBVIE INC.$20Food and BeverageIn-kind items and servicesLUMIGAN Drug, EYE CARE2023
2023-03-27LENSAR, Inc.$16Food and BeverageCash or cash equivalentLENSAR LASER SYSTEM Device, OPHTHALMOLOGY2023
2023-03-24Glaukos Corporation$15Food and BeverageCash or cash equivalent2023
2023-03-20Alcon Vision LLC$14Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2023
2023-03-08ABBVIE INC.$20Food and BeverageIn-kind items and servicesALPHAGAN P Drug, EYE CARE2023
2023-03-08Alcon Vision LLC$14Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2023
2023-03-05Johnson & Johnson Surgical Vision, Inc.$154Food and BeverageIn-kind items and servicesTecnis IOL Device, Optics2023
2023-03-03Glaukos Corporation$33Food and BeverageCash or cash equivalent2023
2023-03-02ABBVIE INC.$104Food and BeverageIn-kind items and servicesDURYSTA Drug, EYE CARE2023
2023-02-20Glaukos Corporation$23Food and BeverageCash or cash equivalent2023
2023-02-20Alcon Vision LLC$21Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2023
2023-02-13Sight Sciences, Inc.$13Food and BeverageIn-kind items and servicesOMNI SURGICAL SYSTEM Device, Ophthalmology2023
2023-01-30Alcon Vision LLC$13Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2023
2023-01-26Glaukos Corporation$120Food and BeverageCash or cash equivalent2023
2023-01-20Glaukos Corporation$15Food and BeverageCash or cash equivalent2023
2023-01-13ABBVIE INC.$10Food and BeverageIn-kind items and servicesDURYSTA Drug, EYE CARE2023
2022-12-23Glaukos Corporation$21Food and BeverageCash or cash equivalentISTENT INJECT W Device, GLAUCOMA2022
2022-12-20Bausch & Lomb Americas Inc.$20Food and BeverageIn-kind items and servicesVYZULTA Drug, Ophthalmology2022
2022-12-08ABBVIE INC.$1,950Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentLUMIGAN Drug, OPHTHALMOLOGY2022
2022-11-14Alcon Vision LLC$101Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2022
2022-11-14Glaukos Corporation$16Food and BeverageCash or cash equivalentISTENT INJECT W Device, GLAUCOMA2022
2022-11-02ABBVIE INC.$3,250Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentXEN GLAUCOMA TREATMENT SYSTEM Device, GLAUCOMA2022
2022-11-02ABBVIE INC.$121Food and BeverageIn-kind items and servicesXEN GLAUCOMA TREATMENT SYSTEM Device, GLAUCOMA2022
2022-11-02ABBVIE INC.$81Travel and LodgingIn-kind items and servicesXEN GLAUCOMA TREATMENT SYSTEM Device, GLAUCOMA2022
2022-11-02ABBVIE INC.$1Travel and LodgingIn-kind items and servicesXEN GLAUCOMA TREATMENT SYSTEM Device, GLAUCOMA2022
2022-11-02ABBVIE INC.$1Travel and LodgingIn-kind items and servicesXEN GLAUCOMA TREATMENT SYSTEM Device, GLAUCOMA2022
2022-10-27RxSight Inc$130Food and BeverageIn-kind items and servicesLIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) Device, Ophthalmology2022
2022-10-26RxSight Inc$23Food and BeverageIn-kind items and servicesLIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) Device, Ophthalmology2022
2022-10-19ABBVIE INC.$21Food and BeverageIn-kind items and servicesLUMIGAN Drug, OPHTHALMOLOGY2022
2022-10-10Glaukos Corporation$22Food and BeverageCash or cash equivalentISTENT INJECT W Device, GLAUCOMA2022
2022-09-19Glaukos Corporation$23Food and BeverageCash or cash equivalentISTENT INJECT W Device, GLAUCOMA2022
2022-09-12Alcon Vision LLC$13,903AcquisitionsCash or cash equivalentHYDRUS Microstent Device, Ophthalmology2022
2022-08-08Bausch & Lomb Americas Inc.$375Compensation for serving as faculty or as a speaker for a medical education programCash or cash equivalentVYZULTA Drug, Ophthalmology2022
2022-08-08Alcon Vision LLC$98Food and BeverageIn-kind items and servicesAcrySof IQ PanOptix UV IOL Device, Ophthalmology2022
2022-08-08Glaukos Corporation$17Food and BeverageCash or cash equivalentISTENT INJECT W Device, GLAUCOMA2022
2022-07-21Alcon Vision LLC$15Food and BeverageIn-kind items and servicesrocklatan Drug, Glaucoma2022
2022-07-14Alcon Vision LLC$22Food and BeverageIn-kind items and servicesHYDRUS Microstent Device, Ophthalmology2022
2022-06-23Johnson & Johnson Surgical Vision, Inc.$68Food and BeverageIn-kind items and servicesCATALYS SYSTEM Device, Optics2022
2022-06-20Glaukos Corporation$15Food and BeverageCash or cash equivalentISTENT INJECT W Device, GLAUCOMA2022
2022-06-16ABBVIE INC.$1,950Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentXEN GLAUCOMA TREATMENT SYSTEM Device, GLAUCOMA2022
2022-06-09ABBVIE INC.$6Food and BeverageIn-kind items and servicesDURYSTA Drug, GLAUCOMA2022
2022-05-25Glaukos Corporation$15Food and BeverageCash or cash equivalentISTENT INJECT W Device, GLAUCOMA2022
2022-05-23ABBVIE INC.$79Food and BeverageIn-kind items and servicesXEN GLAUCOMA TREATMENT SYSTEM Device, GLAUCOMA2022
2022-05-12ABBVIE INC.$4,550Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentLUMIGAN Drug, OPHTHALMOLOGY2022
2022-05-12ABBVIE INC.$938Travel and LodgingIn-kind items and servicesLUMIGAN Drug, OPHTHALMOLOGY2022
2022-05-12ABBVIE INC.$20Food and BeverageCash or cash equivalentLUMIGAN Drug, OPHTHALMOLOGY2022
2022-05-12ABBVIE INC.$13Food and BeverageIn-kind items and servicesLUMIGAN Drug, OPHTHALMOLOGY2022
2022-05-05ABBVIE INC.$112Food and BeverageIn-kind items and servicesLUMIGAN Drug, OPHTHALMOLOGY2022
2022-05-03Bausch & Lomb Americas Inc.$30Food and BeverageIn-kind items and servicesVYZULTA Drug, Ophthalmology2022
2022-04-29ABBVIE INC.$25Food and BeverageIn-kind items and servicesDURYSTA Drug, GLAUCOMA2022
2022-04-27Glaukos Corporation$18Food and BeverageCash or cash equivalentISTENT INJECT W Device, GLAUCOMA2022
2022-04-24Glaukos Corporation$38Food and BeverageCash or cash equivalentISTENT INJECT W Device, GLAUCOMA2022
2022-04-23ABBVIE INC.$1,012Consulting FeeCash or cash equivalentDURYSTA Drug, GLAUCOMA2022
2022-04-22Alcon Vision LLC$94Food and BeverageIn-kind items and servicesrocklatan Drug, Glaucoma2022
2022-04-20Rayner Intraocular Lenses Limited$12Food and BeverageCash or cash equivalentOmidria Drug, Ophthalmology2022
2022-03-18Alcon Vision LLC$19Food and BeverageIn-kind items and servicesAcrySof IQ VIVITY Device, Ophthalmology2022
2022-01-27Alcon Vision LLC$147Food and BeverageIn-kind items and servicesILUX Device, Ophthalmology2022
2022-01-21Allergan, Inc.$17Food and BeverageIn-kind items and servicesDURYSTA Drug, GLAUCOMA2022
2022-01-20SUN PHARMACEUTICAL INDUSTRIES INC.$19Food and BeverageIn-kind items and servicesCequa Drug, Ophthalmology2022
2022-01-19Glaukos Corporation$30Food and BeverageCash or cash equivalentISTENT INJECT W Device, GLAUCOMA2022
2021-12-06Ivantis, Inc$99GiftIn-kind items and servicesHydrus Microstent Device, Ophthalmic Surgery2021
2021-11-19Allergan, Inc.$14Food and BeverageIn-kind items and servicesDURYSTA Drug, GLAUCOMA2021
2021-11-17Omeros Corporation$18Food and BeverageCash or cash equivalentOmidria Drug, Ophthalmology2021
2021-11-14Allergan, Inc.$26Food and BeverageIn-kind items and servicesDURYSTA Drug, GLAUCOMA2021
2021-11-13Aerie Pharmaceuticals, Inc.$126Food and BeverageIn-kind items and services2021
2021-11-12Glaukos Corporation$112Food and BeverageIn-kind items and services2021
2021-11-09Glaukos Corporation$19Food and BeverageIn-kind items and servicesiStent inject W Device, Glaucoma2021
2021-10-21Allergan, Inc.$3,900Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentLUMIGAN Drug, OPHTHALMOLOGY2021
2021-10-21Allergan, Inc.$109Food and BeverageIn-kind items and servicesLUMIGAN Drug, OPHTHALMOLOGY2021

The latest 200 records of 433.

Research payments naming this person as principal investigator

DateCompanyPaid toAmountStudyYear
2025-12-17Glaukos CorporationCENTER FOR SIGHT PL$1,415A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-12-10Glaukos CorporationCENTER FOR SIGHT PL$640Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-11-26Glaukos CorporationUh Cleveland Medical Center$200A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-11-19Glaukos CorporationCENTER FOR SIGHT PL$300A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-11-19Glaukos CorporationCENTER FOR SIGHT PL$370Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-10-22Glaukos CorporationUh Cleveland Medical Center$200A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-10-22Glaukos CorporationUh Cleveland Medical Center$400A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-10-08Glaukos CorporationCENTER FOR SIGHT PL$1,575A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-09-17Glaukos CorporationUh Cleveland Medical Center$200A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-09-10Glaukos CorporationCENTER FOR SIGHT PL$6,640A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-09-10Glaukos CorporationCENTER FOR SIGHT PL$300A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-09-10Glaukos CorporationCENTER FOR SIGHT PL$370Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-08-27Glaukos CorporationGreenphire, Inc.$394A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-08-13Glaukos CorporationOCPC$59A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-08-13Glaukos CorporationOCPC$14A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-08-06Glaukos CorporationCENTER FOR SIGHT PL$1,500A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-07-23Glaukos CorporationGreenphire, Inc.$394A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-07-16Glaukos CorporationUh Cleveland Medical Center$400A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-07-02Glaukos CorporationCENTER FOR SIGHT PL$545Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-07-02Glaukos CorporationCENTER FOR SIGHT PL$150A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-06-18Glaukos CorporationOCPC$17A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-06-11Glaukos CorporationOCPC$15A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-06-04Glaukos CorporationCENTER FOR SIGHT PL$890A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-06-04Glaukos CorporationGreenphire, Inc.$517Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-06-04Glaukos CorporationCENTER FOR SIGHT PL$545Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-05-29Glaukos CorporationGreenphire, Inc.$197A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-05-29Glaukos CorporationGreenphire, Inc.$197A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-05-14Glaukos CorporationGreenphire, Inc.$394A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-05-14Glaukos CorporationOCPC$114A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-05-07Glaukos CorporationCENTER FOR SIGHT PL$1,160Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-04-29Glaukos CorporationUh Cleveland Medical Center$475A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-04-02Glaukos CorporationGreenphire, Inc.$517Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-03-12Glaukos CorporationGreenphire, Inc.$258Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-03-05Glaukos CorporationCENTER FOR SIGHT PL$1,260Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-03-05Glaukos CorporationAmazon.com, Inc.$4A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-02-26Glaukos CorporationGreenphire, Inc.$394A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT2025
2025-02-19Glaukos CorporationGreenphire, Inc.$258Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-02-12Glaukos CorporationCENTER FOR SIGHT PL$5,885Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-02-12Glaukos CorporationPrecision Vision$205Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-01-29Glaukos CorporationGreenphire, Inc.$258Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-01-08Glaukos CorporationCENTER FOR SIGHT PL$6,375Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-01-08Glaukos CorporationGreenphire, Inc.$258Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2025
2025-01-08Glaukos CorporationCENTER FOR SIGHT PL$500Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2025
2024-12-11Glaukos CorporationGreenphire, Inc.$258Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-12-04Glaukos CorporationCENTER FOR SIGHT PL$1,230Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-12-04ABBVIE INC.CENTER FOR SIGHT PL$5,686Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2024
2024-12-04Glaukos CorporationGreenphire, Inc.$258Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-11-06Glaukos CorporationCENTER FOR SIGHT PL$545Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-11-06Glaukos CorporationGreenphire, Inc.$258Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-11-06Glaukos CorporationGreenphire, Inc.$258Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-10-30Glaukos CorporationClinigen Clinical Supplies Management$22Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-10-09Glaukos CorporationGreenphire, Inc.$258Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-10-03ABBVIE INC.CENTER FOR SIGHT PL$1,017Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2024
2024-09-25Glaukos CorporationClinigen Clinical Supplies Management$54Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-09-18Glaukos CorporationGreenphire, Inc.$517Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-08-02ABBVIE INC.CENTER FOR SIGHT PL$2,311Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2024
2024-07-17Glaukos CorporationGreenphire, Inc.$258Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-07-17Glaukos CorporationGreenphire, Inc.$258Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-07-05ABBVIE INC.CENTER FOR SIGHT PL$1,239Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2024
2024-07-03Glaukos CorporationCENTER FOR SIGHT PL$520Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-06-19Glaukos CorporationGreenphire, Inc.$517Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-06-12Glaukos CorporationPrecision Vision$203Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-06-05Glaukos CorporationCENTER FOR SIGHT PL$370Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-06-05ABBVIE INC.CENTER FOR SIGHT$675Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2024
2024-06-05Glaukos CorporationUh Cleveland Medical Center$90Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2024
2024-05-08ABBVIE INC.CENTER FOR SIGHT$1,017Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2024
2024-05-08Glaukos CorporationCENTER FOR SIGHT PL$9,725Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-04-04ABBVIE INC.CENTER FOR SIGHT$1,239Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2024
2024-04-03Glaukos CorporationCommercial Print Management$82Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-03-07ABBVIE INC.CENTER FOR SIGHT$675Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2024
2024-03-06Glaukos CorporationCommercial Print Management$250Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-03-06Glaukos CorporationCENTER FOR SIGHT PL$845Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2024
2024-02-01ABBVIE INC.CENTER FOR SIGHT$3,153Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2024
2024-01-04Glaukos CorporationGreenphire, Inc.$1,055Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular imp2024
2024-01-04ABBVIE INC.CENTER FOR SIGHT$10,827Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2024
2023-12-06Glaukos CorporationCENTER FOR SIGHT PL$415Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2023
2023-11-29Glaukos CorporationClinigen Clinical Supplies Management$83Multicenter Randomized Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular impla2023
2023-11-16Glaukos CorporationUh Cleveland Medical Center$100Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2023
2023-11-07ABBVIE INC.CENTER FOR SIGHT PL$1,239Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2023
2023-11-01Glaukos CorporationCENTER FOR SIGHT PL$895Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2023
2023-10-25Glaukos CorporationClinigen Clinical Supplies Management$83Multicenter Randomized Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular impla2023
2023-10-04Glaukos CorporationClinigen Clinical Supplies Management$470Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2023
2023-09-13Glaukos CorporationCENTER FOR SIGHT PL$560Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2023
2023-09-05ABBVIE INC.CENTER FOR SIGHT PL$1,239Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2023
2023-08-31ABBVIE INC.CENTER FOR SIGHT PL$2,600Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2023
2023-08-16Glaukos CorporationClinigen Clinical Supplies Management$191Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2023
2023-08-15ABBVIE INC.CENTER FOR SIGHT PL$5,525Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2023
2023-08-09ABBVIE INC.CENTER FOR SIGHT PL$9,469Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2023
2023-08-02Glaukos CorporationCENTER FOR SIGHT PL$150Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2023
2023-07-05Glaukos CorporationCENTER FOR SIGHT PL$415Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2023
2023-07-03ABBVIE INC.CENTER FOR SIGHT PL$1,357Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2023
2023-06-28Glaukos CorporationClinigen Clinical Supplies Management$594Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2023
2023-06-02Alcon Research LLCCenter For Sight, Eva I. Liang MD,$8,690A MULTICENTER, OPEN-LABEL ROCKLATAN EVALUATION OF IOP LOWERING EFFICACY AND SAFETY AS REPLACEMENT OF CURRENT MEDICAL THE2023
2023-06-01Glaukos CorporationCENTER FOR SIGHT PL$565Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2023
2023-05-24Glaukos CorporationUh Cleveland Medical Center$270Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2023
2023-04-28Glaukos CorporationCENTER FOR SIGHT PL$560Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2023
2023-04-19Glaukos CorporationUh Cleveland Medical Center$90Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2023
2023-03-29Glaukos CorporationClinigen Clinical Supplies Management$345Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2023
2023-03-29Glaukos CorporationCENTER FOR SIGHT PL$895Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophtha2023
2023-03-09ABBVIE INC.CENTER FOR SIGHT PL$6,000Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Impl2023

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Sarasota CountyVenice city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Venice, FL, county Sarasota County, FL, state Florida; placed by its city name.

MeasurePlace (city or town)
Venice, FL
County
Sarasota County, FL
State
Florida
Population B0100327,479459,54722,416,077
Population, 2020 census P125,463434,00621,538,187
Median age B0100269.257.442.6
Under 18 B010015.3%14.0%19.5%
65 and over B0100161.4%37.5%21.3%
Households B1100115,027212,2048,752,810
Foreign born B0500211.7%13.0%21.9%
Median household income B19013$76,755$83,416$74,568
Median family income B19113$104,962$102,230$89,891
Per capita income B19301$75,070$57,835$42,609
Poverty rate B170019.2%8.6%12.6%
Unemployment rate B230254.8%3.7%4.8%
Civilian labor force B230258,036197,07311,016,578
Mean commute (minutes) B0801326.124.528.0
Bachelor's degree or higher B1500346.3%40.8%34.1%
Housing units B2500120,966266,49210,256,470
Owner-occupied B2500380.4%76.7%67.6%
Renters B2500319.6%23.3%32.4%
Median home value B25077$434,700$411,800$359,000
Median gross rent B25064$1,606$1,818$1,669
White, not Hispanic B0300287.4%80.0%50.4%
Black B030021.2%3.9%14.6%
Hispanic or Latino B030026.0%10.7%27.4%
Asian B030022.1%1.9%2.9%
American Indian and Alaska Native B030020.1%0.1%0.1%

Economy now FRED unemployment 4.4% in Sep 2026 (4.2% a year earlier); per capita personal income $78,345 in 2025, up 38% in five years (+11.3% after inflation); Unemployment rate: 4.9% in Sep 2016 to 4.4% in Sep 2026; low 2.8%, high 14.1% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Venice, FL.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.